Literature DB >> 23650409

Time to tumor growth: a model end point and new metric system for oncology clinical trials.

Michael L Maitland, Lawrence H Schwartz, Mark J Ratain.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23650409     DOI： 10.1200/JCO.2013.49.3635

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  7 in total

1.  Anti-tumoral effects of somatostatin analogs: a lesson from the CLARINET study.

Authors:  M Albertelli; E Nazzari; S Sciallero; F Grillo; S Morbelli; F De Cian; G Cittadini; E Ambrosetti; A Ciarmiello; D Ferone
Journal:  J Endocrinol Invest       Date:  2017-05-26       Impact factor: 4.256

2.  Volume-based growth tumor kinetics as a prognostic biomarker for patients with EGFR mutant lung adenocarcinoma undergoing EGFR tyrosine kinase inhibitor therapy: a case control study.

Authors:  Ji Hyun Lee; Ho Yun Lee; Myung-Ju Ahn; Keunchil Park; Jin Seok Ahn; Jong-Mu Sun; Kyung Soo Lee
Journal:  Cancer Imaging       Date:  2016-03-16       Impact factor: 3.909

3.  Population Pharmacokinetic/Pharmacodynamic Modeling of Tumor Size Dynamics in Pembrolizumab-Treated Advanced Melanoma.

Authors:  M S Chatterjee; J Elassaiss-Schaap; A Lindauer; D C Turner; A Sostelly; T Freshwater; K Mayawala; M Ahamadi; J A Stone; R de Greef; A G Kondic; D P de Alwis
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2016-11-29

4.  Exosomes derived from mesenchymal stem cells enhance radiotherapy-induced cell death in tumor and metastatic tumor foci.

Authors:  Virgínea de Araujo Farias; Francisco O'Valle; Santiago Serrano-Saenz; Per Anderson; Eduardo Andrés; Jesús López-Peñalver; Isabel Tovar; Ana Nieto; Ana Santos; Francisco Martín; José Expósito; F Javier Oliver; José Mariano Ruiz de Almodóvar
Journal:  Mol Cancer       Date:  2018-08-15       Impact factor: 27.401

5.  Tumour growth rate as a tool for response evaluation during PD-1 treatment for non-small cell lung cancer: a retrospective analysis.

Authors:  Deirdre M H J Ten Berge; Daniel P Hurkmans; Ilse den Besten; Jeroen S Kloover; Ron H J Mathijssen; Reno Debets; Egbert F Smit; Joachim G J V Aerts
Journal:  ERJ Open Res       Date:  2019-12-16

6.  Pre-Treatment Tumor Growth Rate Predicts Clinical Outcomes of Patients With Advanced Non-Small Cell Lung Cancer Undergoing Anti-PD-1/PD-L1 Therapy.

Authors:  Li-Na He; Xuanye Zhang; Haifeng Li; Tao Chen; Chen Chen; Yixin Zhou; Zuan Lin; Wei Du; Wenfeng Fang; Yunpeng Yang; Yan Huang; Hongyun Zhao; Shaodong Hong; Li Zhang
Journal:  Front Oncol       Date:  2021-01-19       Impact factor: 6.244

7.  Translating new data to the daily practice in second line treatment of renal cell carcinoma: The role of tumor growth rate.

Authors:  Enrique Grande; Olga Martínez-Sáez; Pablo Gajate-Borau; Teresa Alonso-Gordoa
Journal:  World J Clin Oncol       Date:  2017-04-10
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.